Harbour BioMed is Drug Discovery in United States that focus on HBM Holdings Ltd business. Founded in 2016. They cover business area such as HBM Holdings Ltd, development, differentiated antibody therapeutic, immunology and oncology disease area, its product, Batoclimab, a wide spectrum, autoimmune disease, Tanfanercept, moderate-to-severe dry eye disease, (DED, its geographical segment, Mainland China, United States, Europe.
2016
( 8 years old in 2024 )
HBM Holdings Ltd
-
1 Broadway, 14th Floor
Cambridge, MA 02142
United States
Private
HBM Holdings Ltddevelopmentdifferentiated antibody therapeuticimmunology and oncology disease areaits productBatoclimaba wide spectrumautoimmune diseaseTanfanerceptmoderate-to-severe dry eye disease(DEDits geographical segmentMainland ChinaUnited StatesEurope
* We use standard office opening hours in near Harbour BioMed's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Harbour BioMed is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Harbour BioMed business is focusing on HBM Holdings Ltd.
Harbour BioMed headquarter office and corporate office address is located in 1 Broadway, 14th Floor Cambridge, MA 02142 United States.
Harbour BioMed was founded in United States.
In 2024, Harbour BioMed is currently focus on HBM Holdings Ltd sector.
Above is snippet of Google Trends for "HBM Holdings Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Harbour BioMed, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
